| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |